Antidepressants in Perimenopause: A Complete Overview

Why Antidepressants Come Up in Perimenopause

Many women are surprised to be offered antidepressants when they visit their doctor about perimenopause symptoms. The prescription is not always because a doctor thinks you are depressed. Antidepressants, particularly SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors), have well-documented effects on both mood and vasomotor symptoms like hot flashes and night sweats. Because oestrogen plays a role in regulating serotonin and norepinephrine, the hormonal shifts of perimenopause can destabilise these neurotransmitter systems, producing symptoms that overlap significantly with clinical depression and anxiety. GPs who are less familiar with perimenopause may reach for antidepressants because they look like the right tool. In some cases they are. In other cases, hormone replacement therapy or lifestyle changes may be more appropriate. Understanding why antidepressants are on the table helps you have a more informed conversation with your clinician and make the choice that fits your situation.

SSRIs and SNRIs for Hot Flashes: What the Evidence Shows

Several large clinical trials have shown that low doses of certain SSRIs and SNRIs can reduce hot flash frequency and severity by around 50 to 60 percent. The most studied medications in this context include venlafaxine (an SNRI), paroxetine, escitalopram, and citalopram (all SSRIs). Paroxetine at 7.5 mg is the only non-hormonal medication approved specifically for menopausal hot flashes in the United States. The mechanism appears to involve the thermoregulatory centre in the hypothalamus, which is sensitive to both oestrogen and serotonin levels. When serotonin activity is boosted, the narrow temperature zone that triggers a hot flash appears to widen, reducing the frequency of episodes. Results typically appear within one to two weeks, which is faster than the mood benefits of these drugs. Not all SSRIs work equally well. Fluoxetine, for example, shows weaker effects on hot flashes. Your doctor can help identify which option is best suited to your specific symptom picture and any medications you already take.

Antidepressants vs HRT: Which Is Right for You?

Hormone replacement therapy remains the most effective treatment for vasomotor symptoms in perimenopause, with most studies showing greater reduction in hot flash frequency compared to antidepressants. HRT also addresses a broader range of symptoms including vaginal dryness, sleep disruption related to night sweats, and bone density loss. However, HRT is not suitable for everyone. Women with a history of oestrogen-receptor-positive breast cancer, certain clotting disorders, or active cardiovascular disease may be advised to avoid it. In these situations, SSRIs or SNRIs offer a meaningful alternative that can make a real difference to quality of life. For women whose primary concern is mood, anxiety, or depression alongside physical symptoms, antidepressants may be the more targeted choice. Some women do well on a combination of low-dose HRT and an SNRI, particularly if mood and vasomotor symptoms are both prominent. The decision is individual and should involve a frank discussion of your personal medical history, preferences, and priorities.

Common Side Effects and What to Expect

Starting any antidepressant requires patience and awareness of potential side effects during the adjustment period. The most common early effects include nausea, headaches, mild agitation, and disrupted sleep, most of which settle within two to four weeks. Sexual side effects, particularly reduced libido and difficulty reaching orgasm, are more persistent and can be a significant concern for perimenopausal women who are already experiencing changes in their sexual function due to oestrogen decline. Weight changes and emotional blunting (feeling less responsive emotionally) are also reported by some users. SNRIs can elevate blood pressure at higher doses, so monitoring may be advised. It is important to take these medications consistently at the same time each day, as irregular dosing can cause withdrawal-like symptoms even within a single day. If you experience side effects that concern you, speak with your prescribing clinician before stopping. Most issues can be managed by adjusting the dose or switching to a different medication.

Tapering Off Antidepressants Safely

Stopping antidepressants abruptly can cause discontinuation syndrome, a collection of symptoms including dizziness, electric shock sensations (sometimes called brain zaps), irritability, nausea, and vivid dreams. This is not the same as addiction or dependence in the traditional sense, but it is a physiological response that can be distressing. Tapering the dose gradually over several weeks or months under medical supervision dramatically reduces this risk. Paroxetine and venlafaxine have the highest risk of discontinuation symptoms among commonly used medications, while fluoxetine (which has a naturally long half-life) carries a lower risk. If you have been on antidepressants primarily for perimenopause symptom management and your symptoms have eased, it may be appropriate to reassess the need for the medication. Many women find that their symptoms stabilise over time as they progress through the transition. Any decision to reduce or stop should be made in partnership with your doctor, with a slow, stepwise reduction plan in place.

Talking to Your Doctor About Antidepressants and Perimenopause